Implementation of the first pharmacist-managed ambulatory care anticoagulation clinic in South Korea [PDF]
Hae Mi Choe+3 more
openalex +1 more source
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz+5 more
wiley +1 more source
Student Aboriginal health worker smoking: findings from a training college in Western Australia
Veronica Hoad, Cheryl Hayward
doaj +1 more source
Why expanding public health insurance coverage is not enough to provide effective ambulatory care: policy lessons from Mexico, 2000-2022. [PDF]
Martínez-Valle A.
europepmc +1 more source
Non-urgent emergency department visits by patients from a resident ambulatory care clinic
Peter J. McLeod+4 more
openalex +1 more source
Ambulatory Care of the Osteoarthritis
Eun Kyu Song, Seong Tae Cho
openaire +2 more sources
The QUAD score was developed to promote adherence to clinical practice guidelines for patients with heart failure and a reduced left ventricular ejection fraction <50%. In newly diagnosed patients who had completed therapy titration, we found that patients with an excellent QUAD score had a significant reduction in the risk of mortality or ...
Henry Oluwasefunmi Savage+23 more
wiley +1 more source
Development of routine-data-compatible quality indicators for the management of osteoarthritis of the knee and hip in ambulatory care: a RAND-modified Delphi consensus process. [PDF]
Bock T+5 more
europepmc +1 more source
Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital [PDF]
Monica B. Aspinall+4 more
openalex +1 more source
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra+25 more
wiley +1 more source